Dr. Holzbeierlein on the Management of Bladder Cancer Guidelines

Jeffrey M. Holzbeierlein, MD
Published: Wednesday, Nov 22, 2017



Jeffrey M. Holzbeierlein, MD, professor, director of Urologic Oncology, Department of Urology, University of Kansas Medical Center, discusses the management guidelines for patients with bladder cancer.

The guidelines were a multidisciplinary collaboration involving representatives from the American Urological Association (AUA), Society of Urologic Oncology (SUO), ASCO, American Society for Radiation Oncology (ASTRO), and a patient advocate.

Having a multidisciplinary group brings more validity to the guidelines, explains Holzbeierlein. Bringing together a variety of disciplines educates many people who were not aware of options outside of cystectomy.
 


Jeffrey M. Holzbeierlein, MD, professor, director of Urologic Oncology, Department of Urology, University of Kansas Medical Center, discusses the management guidelines for patients with bladder cancer.

The guidelines were a multidisciplinary collaboration involving representatives from the American Urological Association (AUA), Society of Urologic Oncology (SUO), ASCO, American Society for Radiation Oncology (ASTRO), and a patient advocate.

Having a multidisciplinary group brings more validity to the guidelines, explains Holzbeierlein. Bringing together a variety of disciplines educates many people who were not aware of options outside of cystectomy.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x